4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Simufilam: new trials by email Literature Review of Simufilam trials Research Report on Simufilam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function Simufilam - Hepatic Insufficiency | Phase 1 | Completed | Cassava Sciences, Inc. | 27 | 2024-06-26 | 2025-01-07 |
| Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects Simufilam - Absorption, Metabolism | Phase 1 | Completed | Cassava Sciences, Inc. | 8 | 2024-02-07 | 2025-03-20 |
| Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers simufilam - Healthy Volunteers | Phase 1 | Completed | Cassava Sciences, Inc. | 24 | 2021-05-04 | 2023-08-22 |
| A Safety Study of PTI-125 in Healthy Volunteers 50 mg PTI-125, 100 mg PTI-125, 200 mg PTI-125 - Alzheimer Disease, Early Onset, Alzheimer Disease | Phase 1 | Completed | Pain Therapeutics | 24 | 2017-08-18 | 2021-05-10 |
Alzheimer Disease (1) · Hepatic Insufficiency (1)
Cassava Sciences, Inc. (3) · Pain Therapeutics (1)
United States (4)
George J Atiee, MD (1) · Robert G Bass, MD (1)
R44AG056166 (1)